Select license type

Please Select Linenece Type

Key Benefits

  • Consult directly with our domain leaders and get expert advice regarding the upcoming market.
  • Get the latest market insights and forecasts backed up by powerful research and statistical analysis
  • Customize the report as per your requirements and area of focus to avail great benefits for your business.

our clients
tiltle-brk

client-logo
client-logo2
client-logo3
client-logo4
client-logo
client-logo
client-logo
client-logo

"The quality of representation was outstanding. I never thought that understanding a complex market can be that much easy"

Adam Smith, Associate Director, Bain Capital

"More than just selling a report, the team was more focused towards the understanding of my requirements. Regular updation was the best part."

Koh Vivian, Product Development Manager, Swiss Bio Pharma

"Hats off to expert analysis, the team was very supporting and thanks for not charging me on additional data."

Erin Green, Director, Green Energy Consulting

" I really want to thank Goldstein Research for their efforts to make my project successful. F2F discussion with the market experts was excellent. Keep up the good work guyz "

Jorge Foyo, , Analyst, BCG
Market Research Report

Global Dengue Vaccine Market Outlook 2024: Global Opportunity and Demand Analysis, Market Forecast, 2016-2024

Published On : 2017-09-13 Report Page : 280 Category: Healthcare

Global Dengue Vaccine Market

Market Overview

Dengvaxia (CYD-TDV), first dengue vaccine is a live recombinant tetravalent dengue vaccine that is indicated as a 3 dose series of 0/6/12 month schedule invented by Sanofi Pasteur. CYD-TDV and DENVax are expected to lose market share to the domestically-produced live-attenuated vaccine, TV-003 due to its lower price. Today dengue resides in 125 countries around the world and Aedes aegypti, the primary vector is everywhere, making transmission reduction is the major area of concern.

According to WHO, number of deaths caused by dengue virus was 297, 873 in 2012 and 159 per million in low income, lower-middle income and upper-middle income regions. The global market for dengue vaccines holds the opportunities for drugmakers when the will be able to successfully develop effective vaccines for all age group. The major growth driver of Dengue Vaccine Market is the process of urbanization.

Merger & acquisition is the key strategy for the vendors of dengue market, for instance, Sanofi “Be a Wall against Dengue” disease education campaign to raise awareness on dengue prevention in Singapore, launched under partnership of Pasteur and Ya Kun Kaya Toast in conjunction with ASEAN Dengue Day (15 June 2017). Similarly, Takeda pharmaceutical company and Biological E. limited entered into a partnership for the development and delivery of low-cost combination vaccines. There are 5 vaccines in Phase I-III and 4 first-in-class vaccines in pipeline assessment.

Market Segmentation

By Technology

  • Live attenuated vaccine
  • Chimeric Live attenuated vaccine
  • Subunit vaccine
  • Inactivated vaccine
  • Nucleic acid based vaccine

By End Users

  • Hospital
  • Diagnostic Labs
  • NGO’s
  • Government Institutes
  • Others (retail pharmacies, online pharmacies, etc)

By Region

  • North America (U.S. & Canada) {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}
  •  Latin America (Brazil, Mexico & Rest of Latin America)         {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}
  • Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}
  • Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}
  • Middle East & Africa (GCC, South Africa, North Africa, RoMEA) {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}
  •  Rest of World {Market Size (USD Billion), Growth Analysis (%) and Adoption Rate (%)}

Market Size and Forecast (2016-2024)

Global dengue vaccine market valued USD 0.22 billion in 2016 and is expected to reach USD 1.15 by 2024 at a CAGR of 17% over the forecast period.

Government Institutes dominate the global dengue vaccine market, accounting 45% market share in 2017 and is expected to account for 52% global dengue vaccine market share by 2024 followed by hospitals, diagnostic labs and NGO’s.

Geographically, more than 70% of global dengue vaccine revenue was emanated from APAC in 2016. Countries like Brazil, Mexico, Thailand, Singapore and India are the leading market for dengue vaccine. In America, around 500 million people are at the risk of getting dengue.

Market Drivers and Challenge

The key driving factors of global dengue market are increasing dengue fever occurrence, promising end stage vaccine pipeline, local production of dengue vaccines and innovation of live attenuated tetravalent dengue vaccine. However, less number of skilled professionals and unavailability of optimum diagnostic systems where dengue fever is visualized as a common febrile disease have driven the global dengue vaccine market.

Unplanned and uncontrolled urbanization, stiff competition among existing players, high possibilities of side effects, lack of basic amenities in communities, poor environmental management, and climatic change hinders the global dengue vaccine market. In addition, supply side infrastructure bottlenecks such as surveillance system, standardized diagnostics practice, and cold chain systems for storage of vaccine in resource constrained countries are the restraints responsible for the decline of global dengue vaccine market.

Key Market Players

  • Sanofi Pasteur
  • Synopsis
  • Business Strategy
  • Product Portfolio
  • SWOT Analysis
  • Biological E. Limited
  • Merck & Co.
  • Glaxosmithkline
  • Pfizer
  • Panacea Biotech Ltd.
  • Vabiotech
  • Butantan Institute

Scope Background

Market Synopsis

Market Segmentation

The Global Dengue Vaccine Market is segmented as follows:

  • By Technology (Market Size, Demand Analysis and Growth Analysis)
  • By End-User (Market Size, Demand Analysis and Growth Analysis)

By Regions

  • North America (U.S., Canada) {Market Size, Growth Analysis and Opportunity Analysis}
  • Latin America (Argentina, Mexico, Brazil and Rest of Latin America) {Market Size, Growth Analysis and Opportunity Analysis}
  • Europe (Germany, Italy, Spain, France, The U.K., Netherlands, Sweden, Hungary, Russia, Poland, Rest of Europe) {Market Size, Growth Analysis and Opportunity Analysis}
  • Asia-Pacific (China, India, Singapore, Japan, Hong-Kong, Australia, New Zealand, South Korea and Rest of Asia Pacific) {Market Size, Growth Analysis and Opportunity Analysis}
  • Middle East and North Africa (MENA) {Market Size, Growth Analysis and Opportunity Analysis}
  • Rest of World  {Market Size, Growth Analysis and Opportunity Analysis}

Market Dynamics: Growth Drivers, Restraints and Opportunities

  • Risk Factors
  • Regional Variations
  • Recent Trends and Developments

Key Market Players

  • Synopsis
  • Business Strategy
  • Product Portfolio
  • SWOT Analysis

Porter’s Five Force Model

Market Landscape: Competition and Beyond

Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem

Expert Analysis

Concluding Remarks


Dengue Vaccine Market- Table of Content

 

1. Research Methodology
1.1. Secondary Research
1.2. Primary Research
1.3. Data Analyzing & Market Size Estimation 
1.4. Research Design
1.5. Bottom-Up & Top-Down Approach
 
2. Market Environment
2.1. Global Economic Overview
2.2. Global Healthcare Expenditure Outlook
2.3. Global Pharmaceutical Industry Outlook
2.4. Global Medical Services Outlook
2.5. Global Healthcare Funding Outlook
2.6. Regulatory Considerations
 
3. Industry Structure
3.1. Target Consumer Group Analysis
3.2. Consumer Trend Analysis
3.3. Dengue Disease Prevalence Analysis
3.4. Target Markets (By Countries)
3.5. Research & Development Outlook
3.6. Healthcare Providers Penetration 
3.7. Competitive Strategies
3.8. Acquisitions & Divestitures
 
4. Executive Summary
4.1. Market Size (USD Million)
4.2. Forecast Analysis (2017-2025)
4.3. Market Share & CAGR (%)
4.4. Regional Share Distribution (%)
 
5. Market Dynamics
5.1. Growth Drivers
5.2. Market Restraints
5.3. Risk Analysis (Demand Risk & Supply Risk Analysis)
5.4. Recent Trends & Developments
5.5. Opportunities for Market Players
 
6. Global Dengue VaccineMarket Segmentation
6.1. Dengue Vaccine Market By Technology(Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.1. Live attenuated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.2. Chimeric Live attenuated vaccine(Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.3. Subunit vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.4. Inactivated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.5. Nucleic acid based vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.6. Market Attractiveness of Dengue Vaccine Market by Technology 
6.1.7. BPS Analysis ofDengue Vaccine Market by Technology
 
6.2. Dengue Vaccine Market By End Users (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.1. Hospital (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.2. Diagnostic Labs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.3. NGO’s (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.4. Government Institutes (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.5. Others (retail pharmacies, online pharmacies, etc) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.6. Market Attractiveness of Dengue Vaccine Market by End Users
6.2.7. BPS Analysis Dengue of Vaccine Market by End Users
 
6.3. Dengue Vaccine Market By Region (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
 
6.3.1. North AmericaDengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
6.3.1.1. North America Dengue Vaccine MarketBy Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.3.1.1.1. U.S. Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.1.2. Canada Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.1.3. Market Attractiveness Dengue Vaccine Market by Country
6.3.1.1.4. BPS Analysis Dengue Vaccine Market by Country
 
6.3.1.2. North America Dengue Vaccine Market By Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.2.1. Live attenuated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.2.2. Chimeric Live attenuated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.2.3. Subunit vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.2.4. Inactivated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.2.5. Nucleic acid based vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.2.6. Market Attractiveness of Dengue Vaccine Market by Technology 
6.3.1.2.7. BPS Analysis of Dengue Vaccine Market by Technology
 
6.3.1.3. North America Dengue Vaccine Market By End Users (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.3.1. Hospital (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.3.2. Diagnostic Labs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.3.3. NGO’s (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.3.4. Government Institutes (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.3.5. Others (retail pharmacies, online pharmacies, etc) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1.3.6. Market Attractiveness of Dengue Vaccine Market by End Users
6.3.1.3.7. BPS Analysis Dengue of Vaccine Market by End Users
 
6.3.2. Europe Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
6.3.2.1. Europe Dengue Vaccine Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.3.2.1.1. UK Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.1.2. France Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.1.3. Italy  Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.1.4. Germany Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.1.5. Spain Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.1.6. Hungary Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.1.7. Sweden Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.1.8. Russia Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.1.9. Poland Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.1.10. Rest of EuropeDengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.1.11. Market Attractiveness of Dengue Vaccine Market by Country
6.3.2.1.12. BPS Analysis of Dengue Vaccine Market by Country
 
6.3.2.2. Europe Dengue Vaccine Market By Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.2.1. Live attenuated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.2.2. Chimeric Live attenuated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.2.3. Subunit vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.2.4. Inactivated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.2.5. Nucleic acid based vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.2.6. Market Attractiveness of Dengue Vaccine Market by Technology 
6.3.2.2.7. BPS Analysis of Dengue Vaccine Market by Technology
 
6.3.2.3. Europe Dengue Vaccine Market By End Users (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.3.1. Hospital (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.3.2. Diagnostic Labs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.3.3. NGO’s (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.3.4. Government Institutes (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.3.5. Others (retail pharmacies, online pharmacies, etc) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2.3.6. Market Attractiveness of Dengue Vaccine Market by End Users
6.3.2.3.7. BPS Analysis Dengue of Vaccine Market by End Users
 
6.3.3. Middle East & Africa Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
6.3.3.1. Middle East & Africa Dengue Vaccine Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.3.3.1.1. Gulf Cooperation Council Countries (GCC) Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.1.2. South Africa Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.1.3. North Africa Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.1.4. Rest of Middle East and Africa Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.1.5. Market Attractiveness of Dengue Vaccine Market by Country 
6.3.3.1.6. BPS Analysis of Dengue Vaccine Market by Country
 
6.3.3.2. Middle East & Africa Dengue Vaccine Market By Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.2.1. Live attenuated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.2.2. Chimeric Live attenuated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.2.3. Subunit vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.2.4. Inactivated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.2.5. Nucleic acid based vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.2.6. Market Attractiveness of Dengue Vaccine Market by Technology 
6.3.3.2.7. BPS Analysis of Dengue Vaccine Market by Technology
 
6.3.3.3. Middle East & Africa Dengue Vaccine Market By End Users (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.3.1. Hospital (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.3.2. Diagnostic Labs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.3.3. NGO’s (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.3.4. Government Institutes (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.3.5. Others (retail pharmacies, online pharmacies, etc) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3.3.6. Market Attractiveness of Dengue Vaccine Market by End Users
6.3.3.3.7. BPS Analysis Dengue of Vaccine Market by End Users
 
6.3.4. Latin America Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
6.3.4.1. Latin America Dengue Vaccine Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.3.4.1.1. Brazil Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.1.2. Mexico Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.1.3. Rest of Latin America Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.1.4. Market Attractiveness of Dengue Vaccine Market by Country 
6.3.4.1.5. BPS Analysis of Dengue Vaccine Market by Country
 
6.3.4.2. Latin America Dengue Vaccine Market By Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.2.1. Live attenuated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.2.2. Chimeric Live attenuated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.2.3. Subunit vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.2.4. Inactivated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.2.5. Nucleic acid based vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.2.6. Market Attractiveness of Dengue Vaccine Market by Technology 
6.3.4.2.7. BPS Analysis of Dengue Vaccine Market by Technology
 
6.3.4.3. Latin America Dengue Vaccine Market By End Users (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.3.1. Hospital (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.3.2. Diagnostic Labs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.3.3. NGO’s (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.3.4. Government Institutes (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.3.5. Others (retail pharmacies, online pharmacies, etc) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4.3.6. Market Attractiveness of Dengue Vaccine Market by End Users
6.3.4.3.7. BPS Analysis Dengue of Vaccine Market by End Users
 
6.3.5. Asia Pacific (APAC) Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
6.3.5.1. Asia Pacific Dengue Vaccine Market By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.3.5.1.1. China Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.1.2. Japan Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.1.3. India Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.1.4. Singapore Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.1.5. South Korea Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.1.6. Australia Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.1.7. New Zealand Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.1.8. Rest of APAC Dengue Vaccine Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.1.9. Market Attractiveness of Dengue Vaccine Market by Country 
6.3.5.1.10. BPS Analysis of Dengue Vaccine Market by Country
 
6.3.5.2. Asia Pacific Dengue Vaccine Market By Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.2.1. Live attenuated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.2.2. Chimeric Live attenuated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.2.3. Subunit vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.2.4. Inactivated vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.2.5. Nucleic acid based vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.2.6. Market Attractiveness of Dengue Vaccine Market by Technology 
6.3.5.2.7. BPS Analysis of Dengue Vaccine Market by Technology
 
6.3.5.3. Asia Pacific Dengue Vaccine Market By End Users (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.3.1. Hospital (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.3.2. Diagnostic Labs (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.3.3. NGO’s (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.3.4. Government Institutes (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.3.5. Others (retail pharmacies, online pharmacies, etc) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5.3.6. Market Attractiveness of Dengue Vaccine Market by End Users
6.3.5.3.7. BPS Analysis Dengue of Vaccine Market by End Users
 
7. Competitive Outlook
7.1. Market Share of Major Players (2016)
7.2. Company Profiles
7.2.1. Sanofi Pasteur
7.2.1.1. Company Synopsis
7.2.1.2. Business Strategy
7.2.1.3. Product Portfolio
7.2.1.4. SWOT Analysis
7.2.2. Biological E. Limited
7.2.3. Merck & Co.
7.2.4. Glaxosmithkline
7.2.5. Pfizer 
7.2.6. Panacea Biotech Ltd.
7.2.7. Vabiotech
7.2.8. Butantan Institute
 
8. Porter’s Five Force Model
9. Market Landscape: Competition and Beyond
10. Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem
11. Expert Analysis
12. Concluding Remarks

Global Dengue Vaccine Market Outlook 2024: Global Opportunity and Demand Analysis, Market Forecast, 2016-2024

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

Send Enquiry


Need more information about this report ?


Send Enquiry

Contact us

  • (U.S.) - +1-646-568-7747
  • (Canada) - +1-437-886-1181
  • (U.K.) - +44-203-318-6627
  • (India) - + 91-120-473-0422
  • info@goldsteinresearch.com